Technology
Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.
Molly Gibson, president of future science at Lila Sciences, describes the company's scientific superintelligence computer that analyzes various branches of science and creates hypotheses to help researchers find treatments or cure diseases.
The AI-powered software allows clinicians to ask questions about a patient's medical records.
The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.
HIMSS25
Independent accreditation is essential to ensure that health technology and health organizations are compliant with HIPAA, NIST and other standards, says Kathryn Ayers Wickenhauser, DirectTrust's chief strategy officer.
Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.
The aim is to use See-Mode's thyroid ultrasound as a way to enhance workflow and diagnostic accuracy at RadNet imaging centers.
Elsa provides a secure platform for scientific reviewers and investigators to access internal documents.
The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.
HIMSS25
Getting every image, anywhere, to anyone who has the right to the image, including physicians and patients through the personal health record, is a key goal, says Dr. David Kaelber, Cleveland MetroHealth's chief medical informatics officer.